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Abstract—Predictive models in acute care settings must be able to immediately recognize precipitous changes in a patient’s status
when presented with data reflecting such changes. Recurrent neural networks (RNN) have become common for training and deploying
clinical decision support models. They frequently exhibit a delayed response to acute events. New information must propagate through
the RNN’s cell state memory before the total impact is reflected in the model’s predictions. This work presents input data perseveration
as a method of training and deploying an RNN model to make its predictions more responsive to newly acquired information: input data
is replicated during training and deployment. Each replication of the data input impacts the cell state and output of the RNN, but only
the output at the final replication is maintained and broadcast as the prediction for evaluation and deployment purposes. When
presented with data reflecting acute events, a model trained and deployed with input perseveration responds with more pronounced
immediate changes in predictions and maintains globally robust performance. Such a characteristic is crucial in predictive models for
an intensive care unit.
Index Terms—Recurrent Neural Network, Long Short-Term Memory, Acute Clinical Events, Electronic Medical Records.
F
1 INTRODUCTION
1.1 The Problem
Critical care environments require rapid decision making.
To be meaningful, predictive models in these settings must
immediately recognize precipitous changes in a patient’s
state when presented with data reflecting such changes [1],
[2]. Newly acquired information must be integrated quickly
with the existing understanding of the patient’s state to
inform clinical decisions.
Long Short-Term Memory (LSTM) models [3] are a type
of Recurrent Neural Network (RNN) architecture and have
become increasingly popular for modeling tasks in clinical
settings, including Intensive Care Units (ICUs) [4], [5], [6],
[7], [8], [9], [10], [11]. It is occasionally noted that RNNs, in-
cluding LSTM models, exhibit some lag after acquiring new
information [12]. This characteristic is frequently observed
in stock prediction tasks where the apparent predictive
capability of a model is comparable to a model that predicts
the last observed stock price [13], [14]. However, the inter-
section of deep learning and healthcare, though ever widen-
ing, has a paucity of literature on this phenomenon. Com-
monly reported metrics such as Area Under the Receiver
Operating Characteristic Curve, sensitivity, specificity, and
mean absolute errors mask certain behaviors of RNN based
models.
RNN models require computational cycles to incorpo-
rate new data into their memory cell [15]. There are two
primary observable effects of this, summarized briefly here.
First, what we refer to as a pipe-up period, requires the initial
input to propagate through the memory cell to overcome the
initialized cell state before that input significantly influences
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the predictions. Second, during all subsequent times, new
information only slightly changes the overall prediction of a
model at the time of input and requires propagation through
the memory cell before fully augmenting the model’s pre-
diction. The first phenomenon is a special case of the second.
These two effects are further illustrated in Sections 5 and 6.
1.2 Proposed Solution
This work aims to enable more pronounced changes in RNN
predictions when the model is presented with data indicat-
ing acute clinical events by perseverating the input. Instead
of giving newly available input data to an RNN model only
once, the input is replicated and given to the model multiple
times, during both training and deployment, with only the
prediction of the final perseveration maintained and made
visible to the end-user. This approach provides additional
computational cycles for new data to be incorporated into
the model’s internal states before a prediction is broadcast.
We hypothesized that the resultant model would be able to
react to acute events more quickly than traditionally trained
LSTMs and still maintain overall model performance.
2 RELATED WORKS
Since the seminal paper by R.E. Kalman in 1960 describing
what is now called the Kalman Filter [16], engineers have
been aware of the trade off between integrating historical
data and responding to new data. Most training techniques
used in modern deep learning affect the balance between
relying on historical trends and responding to new infor-
mation; such techniques include dropout, optimizers, and
activation functions [17], [18], [19], [20]. Generating an ap-
propriate target vector (e.g. using changes in values between
consecutive time points instead of predicting raw values) is
another training technique that can prevent generation of an
auto-correlation model [12].
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2Attention mechanisms [21] are sometimes used to man-
age the balance between historical and new data by ap-
pending the entire input sequence to the final hidden layer
of an RNN. Doing so affords the model another opportu-
nity to learn weights which expose the moments in time
series data most relevant to the predictions. Attention net-
works were originally developed for post-hoc sequence-
to-sequence modeling tasks such as image captioning and
neural machine translation which permit access to the entire
input sequence when making predictions [21], [22]. An
attention mechanism was applied by Zhang, et al. to predict
risk of future hospitalization using medical records from a
fixed observation window. [23].
3 DATA
3.1 Clinical Data Sources
Data for this work were extracted from de-identified obser-
vational clinical data collected in Electronic Medical Records
(EMR, Cerner) in the Pediatric Intensive Care Unit (PICU) of
Children’s Hospital Los Angeles (CHLA) between January
2009 and February 2019. The CHLA Institutional Review
Board (IRB) reviewed the study protocol and waived the
need for IRB approval. A patient record included static
information such as gender, race, and discharge disposi-
tion at the end of an ICU episode, defined as a contigu-
ous admission in the PICU. A patient may have multiple
episodes. The EMR for an episode also contained irregu-
larly, sparsely and asynchronously charted measurements of
physiologic observations (e.g. heart rate, blood pressure),
laboratory results (e.g. creatinine, glucose level), drugs (e.g.
epinephrine, furosemide) and interventions (e.g. intubation,
oxygen level). Episodes without discharge disposition were
excluded, leaving 12,826 episodes (9,250 patients) in the final
dataset.
Prior to any of the computational experiments described
here, the episodes were randomly partitioned into three
sets: a training set for deriving model weights, a validation
set for optimizing hyper-parameters, and a holdout test set
for measuring performance. To minimize bias in the per-
formance evaluation metrics, partitioning was done at the
patient level, i.e. all episodes from a single patient belonged
to only one of these sets: 60% in the training set, 20% in the
validation set, and 20% in the test set. No other stratification
was applied. Table 1 displays basic characteristics of the
resulting data partitions.
Preprocessing steps described in previous work [24]
converted each episode data to a matrix structure amenable
to machine learning model development. A row of values
in this matrix represented measurements (recorded or im-
puted) of different variables at one particular time, while
a column contained values of a single variable at different
times. A complete list of variables used as model inputs
can be found in Appendix A. Note that diagnoses, while
available in the EMR, were not used as input features.
3.2 Target Outcome
ICU mortality was chosen as the target outcome because
it is a simple, unambiguous outcome. Importantly, risk of
mortality is used commonly as a proxy for severity of illness
TABLE 1: Basic demographics of data used in this study for
each data partition.
training validation test overall
Number of episodes 7663 2541 26221 12826
Number of patients 5551 1850 18501 9251
Mortality rate 0.035 0.037 0.043 0.037
Fraction male 0.56 0.55 0.58 0.56
Age mean (years) 7.99 8.23 8.09 8.06
std dev 6.45 6.51 6.35 6.44
Fig. 1: The perseverating recurrent neural network (PRNN)
is an RNN with repeating inputs. Each input vector associ-
ated with a particular time is replicated k times, and only
the output from the last replication is considered as the
prediction for that time. The diagram above illustrates the
process for k = 3.
in critical care [25], [26], [27], [28]. The overall mortality rate
of the data was 3.7% (Table 1).
4 RNN MODELS
Many-to-many recurrent neural network models, consist-
ing of stacked Long Short-Term Memory (LSTM) layers
followed by a dense layer, were trained to predict ICU
mortality of each patient episode. All the models output
a probability of survival at each distinct time point where
an observation or measurement of the patient was made,
generating a trajectory of scores that reflect the changing
status of a patient during their ICU episode.
The baseline RNN model was trained in the traditional
manner: when the model acquires new data x(ti), it gener-
ates and immediately broadcasts a prediction y(ti). Other
models which share the architecture of the baseline RNN
model were trained using input perseveration: the same x(ti)
vector was repeatedly given as input to the RNN model k
times, where k is a controllable parameter. While all k out-
puts – corresponding to the k times that x(ti) was given to
the model – are used for optimization during training, only
the last one is maintained and broadcast as the prediction at
time ti during performance assessment and deployment. We
call these models perseverating recurrent neural networks
(PRNN). Figure 1 illustrates a PRNN model with k = 3.
Note that the baseline RNN can be considered as a PRNN
with k = 1. Input perseveration provides the internal cell
state memory of the RNN additional computational cycles
3Fig. 2: Overview of a standard RNN model with a causal
attention layer.
TABLE 2: Hyperparameters for all permutations of the
PRNN.
Hyperparameter Value
Number of LSTM Layers 3
Hidden Units in LSTM Layers [128, 256, 128]
Batch Size 32
Initial Learning Rate 1e-5
Loss binary cross-entropy
Optimizer rmsprop
Dropout 0.2
Recurrent Dropout 0.2
Regularizer 0.0001
Output Activation sigmoid
to incorporate the current state of the patient into the final
prediction.
An attention network using the same hyperparameters
of the baseline RNN model was also implemented. Most
attention networks have access to the entire sequence of
inputs – both past and future relative to the current one
– when making a prediction at any point in time. However,
continuous monitoring of patient status precludes access to
future information, available in a retrospective study but not
in a real deployment scenario. Therefore, the attention layer
between the last hidden layer and output layer used a causal
mask that exposed only the inputs up to the time when a
prediction is being made [29]. This ensured that the network
did not use future information to make its predictions while
affording it another opportunity to consider the totality
of information up to the current time. See Figure 2 for a
diagram of the model.
All six models – baseline RNN (k = 1), PRNN for
k = 2, 3, 4, 5, and attention RNN – were implemented and
trained using Keras 2.0.7 with the Theano 1.0.2 backend [30],
[31]. For each model, weights were optimized on the train-
ing and validation sets; performance was computed on the
validation set after every epoch (i.e. a full cycle through the
training set), and the best performing weights were saved as
the final model. Table 2 displays the hyperparameters that
were used for all six models. The final models were assessed
for performance metrics on the test set.
5 MODEL ASSESSMENTS
Standard metrics such as the Area Under the Receiver
Operating Characteristic Curve (AUROC), precision, and
recall scores for a binary classification task can capture
a model’s overall predictive performance. However, they
can mask the lag phenomenon displayed by LSTMs that,
although known, is rarely commented on in the literature.
The trajectory of probability of survival predictions should
reflect the evolving state of a patient which can have in-
stantaneous changes. Metrics were designed to quantify a
model’s pipe-up behavior and its ability to capture rapid
changes resulting from clinically adverse events. AUROC
was used to compare overall predictive performance for the
main task – ICU mortality prediction.
5.1 Pipe-Up Behavior
A model’s prediction at the first time step is a function of its
weights, initial state of its memory cells and the first input.
Of these, only the first input varies across different patient
episodes; therefore, the distribution of a model’s prediction
at the first time point of all episodes indicates the model’s
level of reliance on the first input data. We refer to this
period as the pipe-up period.
The mean and standard deviation of the distribution
of all yˆp(t0) predictions, where yˆp(t0) represents the first
prediction for patient episode p, were computed for all
survivors and non-survivors in the test set. These metrics
were computed for all six RNN models described in the
previous section and used to compare their responsiveness
to the first available information about a patient episode.
5.2 Responsiveness to Acute Events
The models were also assessed for their instantaneous re-
sponses to clinically adverse events using an average vari-
ation metric computed from the predictions during such
periods. In consultation with clinicians, the times when any
of the following occurred were defined as acute time points
or intervals:
1) substantial increases in creatinine levels or inotrope
score between two consecutive recordings;
2) substantial decreases in heart rate, mean arterial
pressure, Glasgow Coma Score, blood oxygen level
(SpO2), arterial blood gas (ABG) pH, and venous
blood gas (VBG) pH between two consecutive
recordings;
3) a patient’s heart rate goes to 0.
We quantified substantial changes as those that were in
the top or bottom X percentile (X ∈ {5.0, 1.0, 0.5}) of inter-
measurement changes. For example, a time point ti was
considered acute in terms of creatinine when the increase
in creatinine level from ti−1 to ti was in the top X per-
centile of all creatinine level percent changes between any
two consecutive time points in the test dataset. Similarly,
acute time points for heart rate were those times when the
decrease in heart rate was in the bottom X% of all heart
rate changes between any two consecutive time points of all
test set episodes. Table 3 shows the specific percent change
thresholds indicating acute changes in a patient. Thus, a 32%
4TABLE 3: Thresholds of percent change used to define acute
changes in patient state. Negative thresholds correspond to
the bottom p% of changes and positive thresholds corre-
spond to the top p% of changes, for p ∈ [5, 1, 0.5].
5% 1% 0.5%
Heart Rate -18.8 -31.6 -37.1
Mean Arterial Pressure -23.5 -38.1 -44.2
Glascow Coma Score -50.0 -72.7 -72.7
Pulse Oximetry -5.6 -20.2 -35.1
ABG pH -1.5 -2.9 -3.5
VBG pH -1.4 -2.6 -3.1
Inotrope Score 66.7 150.0 250.0
Creatinine 33.3 60.5 81.8
drop in heart rate between two consecutive measurements
would be in the top 1 percentile, while a 70% increase in
inotrope score would be in the top 5 percentile.
Applying three percentile-based thresholds to define
acute patient state changes meant a total of 25 acuity defini-
tions (2 * 3 increases in measured variables, 6 * 3 decreases
in measured variables, and zero heart rate) used to assess
models’ responses when such events occur. It is important
to note that we are not proposing these as general definitions
of clinical acuity. They were designed to capture events
that indicate precipitous changes in a patient’s state with
high specificity to assess the magnitude of the instantaneous
change in predicted probability of survival.
Each previously defined acute event, denoted by E,
identified a set of acute time points, denoted by SE(p), for
each patient episode p. Changes in a model’s prediction
at these time points were evaluated through an average
temporal variation metric given by:
VE(p) =
100
|SE(p)|
∑
ti∈SE(p)
|yˆp(ti)− yˆp(ti−1)|, (1)
where yˆp(ti) is the prediction for patient episode p at time
point ti, and |SE(p)| is the number of time points in SE(p).
This metric measures how much the predicted probability
of survival (scaled to [0, 100]) changed, on average, at the
defined acute time points of an episode. Model A having a
higher AV (p) than model B means that when both models
were presented with data reflecting a precipitous change in
a patient’s state, model A’s prediction underwent a greater
change than model B’s prediction, indicating that model A
had a more pronounced response to the acute event. The
average of this metric across Np episodes gives a measure
of the model’s overall responsiveness to acute event E of
those episodes:
V¯E =
1
Np
∑
p
VE(p). (2)
5.3 Overall Predictive Performance
Model predictions at ICU admission and at 1, 3, 6, 12, and
24 hours after ICU admission were evaluated for predictive
performance via the AUROC. Performance was only mea-
sured for episodes lasting at least 24 hours to maintain a
consistent cohort across time slices (n = 2130, mortality rate
= 0.046).
6 RESULTS
Figure 3 illustrates trajectories of probability of survival
predictions from two models, the baseline RNN (k = 1) and
a PRNN with k = 5, for two non-surviving episodes. In the
first episode (top), the patient had a rapid increase of crea-
tinine level, which indicates kidney dysfunction, about 500
hours after ICU admission. When presented with this de-
fined acute event, the baseline model’s prediction dropped
from 0.89 to 0.88, while the PRNN model dropped from
0.75 to 0.71. In the second episode (bottom), the patient’s
Glasgow Coma Score decreased from 7 to 4. When presented
with this defined acute event, the baseline model’s probabil-
ity of survival prediction dropped from 0.76 to 0.70, while
the PRNN model dropped from 0.69 to 0.50. In either case,
the PRNN model’s immediate response to an acute event
was more pronounced than that of the baseline RNN model.
Further, the trajectory of the baseline RNN’s predictions
after either acute event appears to lag behind that of the
PRNN by about 1-2 hours.
The remainder of this section describes the results from
aggregating the assessment metrics described in Section 5
across episodes in the test dataset.
6.1 Pipe-Up Behavior
Figure 4 shows the distribution of predictions at the first
observation. The mean prediction for survivors increased
with the perseveration parameter k: from 0.70 (k = 1) to
0.90 (k = 5). For both survivors and non-survivors, the
standard deviation increased with k. The increase of stan-
dard deviation was more pronounced in the non-survivors,
going from from 0.04 at k = 1 to 0.13 at k = 5.
6.2 Responsiveness to Acute Events
Figure 5 displays the average variation as a function of k
and acuity definitions. Two trends are apparent. First is the
behavior of average variation as a function of percentile
change in a given physiologic observation or intervention.
For each model, the resulting average variation increased as
the change in a physiologic or intervention variable became
more severe (ie. from 95.0 to 99.5 percentile). Second, a
clear positive correlation between k and average variation
is evident across all definitions of acuity. The attention layer
generally demonstrated lower average variation than the
k = 1 model.
6.3 Overall Predictive Performance
Table 4 summarizes the AUROC of model predictions at
different times after ICU admission of all episodes in the
test set that lasted at least 24 hours. The AUROC gains
due to input perseveration were larger at the earlier times
of prediction (t ≤ 6 hours), increasing at the first hour
from 0.77 when k = 1 to 0.83 when k = 5. By the 12th
hour, the AUROC did not significantly change with the
perseveration parameter k. Performance increases for all
models as additional hours of observation are available.
Adding an attention layer displayed similar performance
as the baseline model (k = 1) at all evaluation times.
5Fig. 3: Two examples of predictions following acute events
in two individual patient episodes. The blue curves cor-
respond to the baseline (k = 1) model, while the orange
curves correspond to the PRNN model with k = 5. The
dotted vertical lines denote onset of an acute event for each
patient: (A) a patient experiencing kidney failure and the
moment of increased creatinine and blood urea nitrogen
(BUN); (B) a patient’s Glasgow Coma Score decreasing from
7 to 4, indicating significantly reduced levels of conscious-
ness.
7 DISCUSSION
Real time predictions for ICU mortality are proxies for
severity of illness [28], [32], [33] and should reflect acute
changes in a patient. The examples in Figure 3 show that the
mortality model trained with input perseveration (PRNN
with k = 5) responded more pronouncedly and immedi-
ately than the traditionally trained model (k = 1) when
both were presented with data reflecting acute changes.
Subsequent to the acute changes, the responses of the tra-
ditional RNN appeared to lag behind the PRNN’s. Standard
TABLE 4: Test set AUROCs for the mortality prediction at
admission and after 1, 3, 6, 12, and 24 hours of observation.
Only the patient episodes lasting at least 24 hours of ICU
time were evaluated.
k 0hr 1hr 3hr 6hr 12hr 24hr
1 0.716 0.766 0.859 0.895 0.914 0.952
2 0.729 0.804 0.871 0.902 0.916 0.956
3 0.731 0.819 0.875 0.902 0.916 0.955
4 0.735 0.821 0.876 0.900 0.915 0.954
5 0.736 0.832 0.883 0.905 0.919 0.955
attention 0.723 0.734 0.853 0.892 0.910 0.949
metrics such as AUROCs for classification or mean absolute
errors for continuous regression often mask this predictive
lag and other deleterious behaviors that can be detrimental
in critical or intensive care settings where rapid recognition
and response are crucial.
Input perseveration provides the RNN’s internal cells
additional computational cycles to incorporate the current
state of the patient into the final prediction. The effect of
this method was measured by metrics designed to capture
a model’s immediate responses to newly acquired data.
The variation metric described in Section 5.2 compares
the models’ immediate responses to data indicating precip-
itous changes in a patient’s status. These changes require
quick reaction time from the care team, therefore capturing
them in the predictions is important. The comparison of
variation metrics from the different models (Figure 5) shows
that the LSTM became more responsive to acute clinical
events as the level of perseveration, k, increased. When k
increased from 1 to 5, the variation metric corresponding to
the defined precipitous events increased by a factor of 2-3
times. They also show that a given model’s responsiveness
increased with more acute events (i.e. those belonging to
higher percentile changes for a given physiologic or inter-
vention variable). This result is consistent with expectations
about the variation metric. For example, one would expect
the change in predictions of those with larger drops in blood
gas level to be greater than those of less severe drops.
Figure 4 compares the distributions of initial predictions
generated by the different models. Since the first prediction
is a function of both the initial input (which varies across
episodes) and the initial cell state memory (which is fixed),
a wider distribution of these predictions across episodes
indicates a higher reliance on the initial input. This is impor-
tant because children admitted to the PICU have different
severities of illness [25], [27]. Increasing k resulted in a
wider distribution as measured by the standard deviation.
The increase was greater for the non-surviving population
(σ = 0.04 when k = 1 to σ = 0.13 when k = 5) relative
to the surviving population. This is again consistent with
clinical expectations.
Increasing the first prediction’s reliance on the initial
measurement – as achieved by the PRNN models with
higher k – also resulted in higher AUROC at ICU admission
(Table 4). As the models observed the patient longer, their
AUROCs increased as expected. Importantly, the increase of
AUROC due to perseveration was greater at the early hours
(t ≤ 3) when information is most scarce, with the 1-hour
AUROC increasing from 0.77 when k = 1 to 0.83 when
k = 5. This means that predictive clinical models relying
6Fig. 4: Distribution of model predictions at the first available observation for survivors and non-survivors
Fig. 5: Comparison of the average variation metric V¯E of different models as defined by Equation 2 across all test set
episodes, where the events are defined by: A) a 95th percentile change; B) a 99th percentile change; C) a 99.5th percentile
change; D) a cardiac arrest.
on scarce data for early detection could benefit from the
perseveration approach.
Adding a causal attention layer to the baseline (k = 1)
model had no apparent performance improvement in any
of the metrics. The attention network theoretically can put
more weight to the most recent state than to the previous
ones. The results indicate that this mechanism did not
improve on what the baseline LSTM’s gates were already
doing, but persistently giving the same input to the model
– i.e. perseverating the input – did.
There are limitations to the perseverated input approach.
Although LSTMs are theoretically good at understanding
temporal trends through their memory cells, there remain
practical limitations to how long prior information can
be maintained to inform future predictions [34], [35]. The
PRNN has the potential to exacerbate these algorithmic
deficiencies because of the memory cell’s prolonged expo-
sure to the same data. A comprehensive assessment of the
impact of a potential reduction in temporal memory was not
performed. However, the basic data perseveration technique
can easily be generalized to any sequential data.
Additionally, perseveration increases the number of se-
quences requiring computation. Perseveration is used dur-
ing both training and inference, and the compute time scales
linearly for both, commensurate with the level of persever-
ation. However, the time required for inference is on the
order of 30ms for k = 1 (baseline) and 150ms for k = 5
on an NVIDIA Titan RTX. Since the recording frequency
is approximately every 15 minutes, these computational
burdens do not hinder deployment.
Finally, this proof-of-concept study used only a single
clinical outcome (ICU mortality) and data from a single
7center. Future work will examine the effect of perseverating
the data input on other important clinical tasks such as risk
of desaturation, sepsis, and renal failure.
8 CONCLUSION
This work demonstrates that perseverated data input in-
creases the responsiveness of LSTM models to a variety
of acute changes to patient state and also significantly in-
creases predictive performance in the early hours following
admission. The PRNN is a simple solution to the predictive
lag exhibited by standard LSTMs when encountering an
acute event and may enable more rapid responses to critical
conditions.
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8APPENDIX A
EMR VARIABLES
TABLE 5: EMR variables (demographics, vitals and labs) in patient episode matrix. Demographics such as gender and
race/ethnicity were encoded as binary variables.
Demographics and Vitals
Age Sex F Sex M race African American
race Asian/Indian/Pacific Islander race Caucasian/European Non-Hispanic race Hispanic race unknown
Abdominal Girth FLACC Pain Face Left Pupillary Response Level Respiratory Effort Level
Activity Level FLACC Pain Intensity Level of Consciousness Respiratory Rate
Bladder pressure FLACC Pain Legs Lip Moisture Level Right Pupil Size After Light
Capillary Refill Rate Foley Catheter Volume Mean Arterial Pressure Right Pupil Size Before Light
Central Venous Pressure Gastrostomy Tube Volume Motor Response Level Right Pupillary Response Level
Cerebral Perfusion Pressure Glascow Coma Score Nasal Flaring Level Sedation Scale Level
Diastolic Blood Pressure Head Circumference Near-Infrared Spectroscopy SO2 Skin Turgor edema
EtCO2 Heart Rate Nutrition Level Skin Turgor turgor
Extremity Temperature Level Height Oxygenation Index Systolic Blood Pressure
Eye Response Level Hemofiltration Fluid Output PaO2 to FiO2 Temperature
FLACC Pain Activity Intracranial Pressure Patient Mood Level Verbal Response Level
FLACC Pain Consolability Left Pupil Size After Light Pulse Oximetry WAT1 Total
FLACC Pain Cry Left Pupil Size Before Light Quality of Pain Level Weight
Labs
ABG Base excess CBG PCO2 GGT Neutrophils %
ABG FiO2 CBG PO2 Glucose PT
ABG HCO3 CBG TCO2 Haptoglobin PTT
ABG O2 sat CBG pH Hematocrit Phosphorus level
ABG PCO2 CSF Bands% Hemoglobin Platelet Count
ABG PO2 CSF Glucose INR Potassium
ABG TCO2 CSF Lymphs % Influenza Lab Protein Total
ABG pH CSF Protein Lactate RBC Blood
ALT CSF RBC Lactate Dehydrogenase Blood RDW
AST CSF Segs % Lactic Acid Blood Reticulocyte Count
Albumin Level CSF WBC Lipase Schistocytes
Alkaline phosphatase Calcium Ionized Lymphocyte % Sodium
Amylase Calcium Total MCH Spherocytes
Anti-Xa Heparin Chloride MCHC T4 Free
B-type Natriuretic Peptide Complement C3 Serum MCV TSH
BUN Complement C4 Serum MVBG Base Excess Triglycerides
Bands % Creatinine MVBG FiO2 VBG Base excess
Basophils % Culture Blood MVBG HCO3 VBG FiO2
Bicarbonate Serum Culture CSF MVBG O2 Sat VBG HCO3
Bilirubin Conjugated Culture Fungus Blood MVBG PCO2 VBG O2 sat
Bilirubin Total Culture Respiratory MVBG PO2 VBG PCO2
Bilirubin Unconjugated Culture Urine MVBG TCO2 VBG PO2
Blasts % Culture Wound MVBG pH VBG TCO2
C-Reactive Protein D-dimer Macrocytes VBG pH
CBG Base excess ESR Magnesium Level White Blood Cell Count
CBG FiO2 Eosinophils % Metamyelocytes %
CBG HCO3 Ferritin Level Monocytes %
CBG O2 sat Fibrinogen Myelocytes %
9TABLE 6: EMR Variables (drugs and interventions) in baseline patient episode matrix.
Drugs
Acetaminophen/Codeine inter Clonazepam inter Ipratropium Bromide inter Oseltamivir inter
Acetaminophen/Hydrocodone inter Clonidine HCl inter Isoniazid inter Oxacillin inter
Acetaminophen inter Cyclophosphamide inter Isradipine inter Oxcarbazepine inter
Acetazolamide inter Desmopressin inter Ketamine cont Oxycodone inter
Acyclovir inter Dexamethasone inter Ketamine inter Pantoprazole inter
Albumin inter Dexmedetomidine cont Ketorolac inter Penicillin G Sodium inter
Albuterol inter Diazepam inter Labetalol inter Pentobarbital inter
Allopurinol inter Digoxin inter Lactobacillus inter Phenobarbital inter
Alteplase inter Diphenhydramine HCl inter Lansoprazole inter Phenytoin inter
Amikacin inter Dobutamine cont Levalbuterol inter Piperacillin/Tazobactam inter
Aminophylline cont Dopamine cont Levetiracetam inter Potassium Chloride inter
Aminophylline inter Dornase Alfa inter Levocarnitine inter Potassium Phosphat e inter
Amlodipine inter Enalapril inter Levofloxacin inter Prednisolone inter
Amoxicillin/clavulanic acid inter Enoxaparin inter Levothyroxine Sodium inter Prednisone inter
Amoxicillin inter Epinephrine cont Lidocaine inter Propofol cont
Amphotericin B Lipid Complex inter Epinephrine inter Linezolid inter Propofol inter
Ampicillin/Sulbactam inter Epoetin inter Lisinopril inter Propranolol HCl inter
Ampicillin inter Erythromycin inter Lorazepam inter Racemic Epi inter
Aspirin inter Factor VII inter Magnesium Sulfate inter Ranitidine inter
Atropine inter Famotidine inter Meropenem inter Rifampin inter
Azathioprine inter Fentanyl cont Methadone inter Risperidone inter
Azithromycin inter Fentanyl inter Methylprednisolone inter Rocuronium inter
Baclofen inter Ferrous Sulfate inter Metoclopramide inter Sildenafil inter
Basiliximab inter Filgrastim inter Metronidazole inter Sodium Bicarbonate inter
Budesonide inter Fluconazole inter Micafungin inter Sodium Chloride inter
Bumetanide inter Fluticasone inter Midazolam HCl cont Sodium Phosphate inter
Calcium Chloride cont Fosphenytoin inter Midazolam HCl inter Spironolactone inter
Calcium Chloride inter Furosemide cont Milrinone cont Sucralfate inter
Calcium Gluconate inter Furosemide inter Montelukast Sodium inter Tacrolimus inter
Carbamazepine inter Gabapentin inter Morphine cont Terbutaline cont
Cefazolin inter Ganciclovir Sodium inter Morphine inter Tobramycin inter
Cefepime inter Gentamicin inter Mycophenolate Mofetl inter Topiramate inter
Cefotaxime inter Glycopyrrolate inter Naloxone HCL cont Trimethoprim/Sulfamethoxazole inter
Cefoxitin inter Heparin cont Naloxone HCL inter Ursodiol inter
Ceftazidime inter Heparin inter Nifedipine inter Valganciclovir inter
Ceftriaxone inter Hydrocortisone inter Nitrofurantoin inter Valproic Acid inter
Cephalexin inter Hydromorphone cont Nitroprusside cont Vancomycin inter
Chloral Hydrate inter Hydromorphone inter Norepinephrine cont Vasopressin cont
Chlorothiazide inter Ibuprofen inter Nystatin inter Vecuronium inter
Ciprofloxacin HCL inter Immune Globulin inter Octreotide Acetate cont Vitamin K inter
Cisatracurium cont Insulin cont Olanzapine inter Voriconazole inter
Clindamycin inter Insulin inter Ondansetron inter
Interventions
Abdominal X Ray Diversional Activity tv NIV Mode Range of Motion Assistance Type
Arterial Line Site ECMO Hours NIV Set Rate Sedation Intervention Level
CT Abdomen Pelvis EPAP Nitric Oxide Sedation Response Level
CT Brain FiO2 Nurse Activity Level Completed Tidal Volume Delivered
CT Chest Gastrostomy Tube Location O2 Flow Rate Tidal Volume Expiratory
Central Venous Line Site HFOV Amplitude Oxygen Mode Level Tidal Volume Inspiratory
Chest Tube Site HFOV Frequency Oxygen Therapy Tidal Volume Set
Chest X Ray Hemofiltration Therapy Mode PEEP Tracheostomy Tube Size
Comfort Response Level IPAP Peak Inspiratory Pressure Ventilator Rate
Continuous EEG Present Inspiratory Time Peritoneal Dialysis Type Ventriculostomy Site
Diversional Activity books MRI Brain Pharmacological Comfort Measures Given Visitor Mood Level
Diversional Activity music Mean Airway Pressure Position Support Given Visitor Present
Diversional Activity play Mechanical Ventilation Mode Position Tolerance Level Volume Tidal
Diversional Activity toys MultiDisciplinaryTeam Present Pressure Support
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